Contify Announces Successful Deployment of Daily Competitive Intelligence Report for a Pharma Client

DELHI, India - Aug. 22, 2019 - PRLog -- Contify, an AI-enabled market and competitive intelligence solutions provider, announced today that it has successfully deployed its platform to generate customized daily competitive intelligence reports for a leading pharma company focused on the development of novel drugs to treat rare diseases.

Through exhaustive monitoring of the pharmaceutical company's competitors and regulatory bodies such as the Food and Drug Administration, European Medicines Agency, Pharmaceuticals and Medical Devices Agency and the National Medical Products Association, Contify enabled automated sourcing and swift dissemination of strategic intelligence updates on a daily basis, not only to senior leadership but organization-wide.

"Contify has transformed the way we conduct secondary market research. It has significantly reduced the time spent on searching for information from a large pool of diverse sources. The platform is our go-to source for reliable intelligence on our competitors and market trends. My colleagues and I wait eagerly, each morning, to receive our daily copy of a refreshing, structured, and beautifully designed newsletter report in our email inboxes." said the Competitive Intelligence Manager of the pharma company.

Contify has published a case study to illustrate how it helped the company to institutionalize a structured approach to market and competitive intelligence (https://www.contify.com/pre-login/brief-case-studies/9204...).

"By successfully configuring our market and competitive intelligence platform to work for a domain as specific as rare diseases, we have yet again demonstrated that with the right combination of artificial intelligence and human intelligence, any organization can drive results by keeping everyone in the entire organization abreast of the latest developments on their competitive landscape," added Mohit Bhakuni, Founder and CEO, Contify.

About the pharmaceutical company

Founded in the early 1980s, this US-based leading pharmaceutical company researches and develop drugs for patients with rare diseases. The company is a member of the Alliance for Biosecurity — a consortium of companies committed to the research and development of vaccines and countermeasures to curb pandemics and bioterrorism.

About Contify

Contify offers an AI-enabled Market and Competitive Intelligence solution (https://www.contify.com/?utm_source=prlog_dig&utm_med...) that tracks information on competitors, customers, and industry segments. It enables users to collect, curate, and share information across the organization. Intelligent (actionable) information is mined by searching and analyzing information from over 200,000 online sources including news, company websites, social media, reviews, discussion forums, job postings, regulatory portals, and more.